We use cookies to make your experience better. To comply with the new e-Privacy directive, we need to ask for your consent to set the cookies. Learn more.
Cav1.3 Ca+2 Channel (S38-8) antibody
Voltage-dependent L-type calcium channel subunit alpha-1D
Calcium channel, L type, alpha-1 polypeptide, isoform 2
Voltage-gated calcium channel subunit alpha Cav1.3
Gene name: CACNA1D, CACH3, CACN4, CACNL1A2, CCHL1A2
Calcium channel, L type, alpha-1 polypeptide, isoform 2
Voltage-gated calcium channel subunit alpha Cav1.3
Gene name: CACNA1D, CACH3, CACN4, CACNL1A2, CCHL1A2
Out of stock
Ref
00096578
Cav1.3 Ca+2 Channel (S38-8) antibody
ID Covalab | mab60065 |
---|---|
Product type | Primary antibodies |
Clonality | Monoclonal antibody |
Clone | S38-8 |
Isotype | IgG1 |
Raised in | Mouse |
Immunogen | Fusion protein corresponding to C terminal amino acids 2025-2161 of Rat Cav1.3 |
Activity cross reaction | Reacts with Cav1.3 from Mouse, Rat, Rabbit, Human. No cross-reactivity against Cav1.2 |
Species | Hu, Ms, Rab, Rat |
Labelling | None |
Form | Purified |
Preservative | NaN3 0.09% |
Target | Cav1.3 Ca+2 Channel |
Uniprot ID | Q01668 |
Gene ID | 776 |
Applications | FC, ICC, IF, IHC, IP, WB |
Working dilutions | Optimal dilutions should be determined by the end user. The following are guidelines only: ICC/IF (1 - 10 µg/ml) WB (1 - 10 µg/ml) Agglutination Use (1 - 2 µg for 10E6 cells) |
Positive control | Rat brain lysate |
Publication | * Freundt JK et al. BMC Pharmacol Toxicol. 2019 Mar 6;20(1):16 (Rab, WB) |
Write Your Own Review